- World rank, 2022–2025
- #11,028 of 28,054 · #22,026 all time
- Rank in China
- #1,971 of 3,058
- Research works
- 255 ▲ 92% vs 2013–17
- Citations
- 4.5k 17.7 per fractional work
- Top-10% rate
- 20.9% record average 16.5%
- Open access
- 55% world 28%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 9.0×. Every wedge is a field page.
- Immunology and Microbiology 9.0×
- Biochemistry, Genetics and Molecular Biology 4.1×
- Pharmacology, Toxicology and Pharmaceutics 3.6×
- Veterinary 2.5×
- Medicine 2.1×
- Agricultural and Biological Sciences 1.7×
- Chemistry 1.5×
- Chemical Engineering 1.4×
- Nursing 1.3×
- Materials Science 0.7×
- Energy 0.5×
- Environmental Science 0.5×
- Engineering 0.5×
- Neuroscience 0.4×
- Dentistry 0.4×
- Mathematics 0.1×
- Social Sciences 0.1×
- Business, Management and Accounting 0.1×
- Computer Science 0.1×
- Economics, Econometrics and Finance 0.1×
- Earth and Planetary Sciences 0.0×
- Physics and Astronomy 0.0×
- Health Professions 0.0×
Which keywords describe research at Sinovac Biotech?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Epidemiology, Vaccine, Immunity, Pandemic, Immunotherapy, Cancer Immunotherapy, Cancer and Pathogenesis.
- Vaccine Adjuvants
- Dendritic Cells
- Monoclonal Antibodies
- H1N1
- Vaccines
- Gene Therapy
- Vaccine Development
- Virus
- Innate Immunity
- spike protein
- Mutation
- CAR T Cells
- Viral Transmission
- Coronavirus
- Tumor Regression
- SARS-CoV-2
- Pathogenesis
- Immunotherapy
- Immunity
- Vaccine
- Epidemiology
- Cancer
- Pandemic
- Cancer Immunotherapy
- Inflammation
- Immune Response
- ACE2 Receptor
- Genomics
- Lymphoma
- Chimeric Antigen Receptor
- antibody
- Biomarkers
- Glycosylation
- Antigen Presentation
- Antibodies
- Tumor Microenvironment
- Gut Microbiota
- Influenza
- Therapeutic Antibodies
- Tumor Antigen
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology17▲ 3.6×38 topics
- Vaccine10▲ 19×10 topics
- Cancer8▲ 5.1×28 topics
- Immunity8▲ 16×7 topics
- Pandemic8▲ 6.2×3 topics
- Immunotherapy7▲ 8.4×12 topics
- Cancer Immunotherapy7▲ 37×3 topics
- Pathogenesis7▲ 11×13 topics
- Inflammation6▲ 2.5×35 topics
- SARS-CoV-26▲ 15×5 topics
- Immune Response6▲ 8.3×14 topics
- Tumor Regression6▲ 41×2 topics
- ACE2 Receptor5▲ 17×2 topics
- Coronavirus5▲ 20×2 topics
- Genomics5▲ 13×6 topics
- Viral Transmission4▲ 25×2 topics
- Lymphoma4▲ 22×2 topics
- CAR T Cells4▲ 47×1 topic
- Chimeric Antigen Receptor4▲ 47×1 topic
- Mutation4▲ 18×2 topics
- antibody4▲ 31×1 topic
- spike protein4▲ 31×1 topic
- Biomarkers4▲ 4.7×11 topics
- Innate Immunity4▲ 10×7 topics
- Glycosylation4▲ 28×3 topics
- Virus4▲ 33×3 topics
- Antigen Presentation4▲ 35×2 topics
- Vaccine Development4▲ 12×7 topics
- Antibodies3▲ 48×2 topics
- Gene Therapy3▲ 14×3 topics
- Tumor Microenvironment3▲ 5.9×7 topics
- Vaccines3▲ 47×3 topics
- Gut Microbiota3▲ 7.0×6 topics
- H1N13▲ 81×1 topic
- Influenza3▲ 60×1 topic
- Monoclonal Antibodies3▲ 27×3 topics
- Therapeutic Antibodies3▲ 33×2 topics
- Dendritic Cells3▲ 24×2 topics
- Tumor Antigen3▲ 34×1 topic
- Vaccine Adjuvants3▲ 34×1 topic
Which research topics does Sinovac Biotech publish most on?
By volume in 2022–2025: CAR-T cell therapy research, SARS-CoV-2 and COVID-19 Research, Influenza Virus Research Studies and Immunotherapy and Immune Responses.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 CAR-T cell therapy research Oncology 4 works
- 2 SARS-CoV-2 and COVID-19 Research Infectious Diseases 4 works
- 3 Influenza Virus Research Studies Epidemiology 3 works
- 4 Immunotherapy and Immune Responses Immunology 3 works
- 5 Respiratory viral infections research Epidemiology 2 works
- 6 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 2 works
- 7 Cancer Immunotherapy and Biomarkers Oncology 2 works
- 8 Viral Infections and Immunology Research Cardiology and Cardiovascular Medicine 2 works
- 9 Vaccine Coverage and Hesitancy Health 1 works
- 10 Viral gastroenteritis research and epidemiology Infectious Diseases 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Sinovac Biotech's research output changed?
Output in 2018–2022 was 92% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Beijing
- Chinese Academy of Sciences
- Tsinghua University
- Peking University
- University of Chinese Academy of Sciences
- Beihang University
- Beijing Institute of Technology
- Chinese Academy of Medical Sciences & Peking Union Medical College
- North China Electric Power University
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.